The central role of the serine protease thrombin in hemostasis and thr
ombosis brought many scientists to develop highly potent and selective
thrombin inhibitors. Thrombin-inhibitor complexes have extensively be
en studied in order to understand structure-function relationships, an
d to design new inhibitors that can be used with broader efficacy over
existing antithrombotic agents. In this paper, we summarize in a comp
arative manner the state of the art on reversible thrombin inhibitors
and we discuss some structural aspects of thrombin-inhibitor interacti
on, which account for the different affinity and potency of these mole
cules. We also report here our approach to develop a new class of synt
hetic, multisite-directed thrombin inhibitors, named hirunorms, design
ed to mimic the distinctive binding mode of hirudin, We emphasize here
that, despite the high specificity of thrombin action, the interactio
n of inhibitors in its active site may occur with quite different mech
anisms.